Kuneš J - Search Results

1

Metabolomics Based on MS in Mice with Diet-Induced Obesity and Type 2 Diabetes Mellitus: the Effect of Vildagliptin, Metformin, and Their Combination.

Tomášová P, Bugáňová M, Pelantová H, Holubová M, Šedivá B, Železná B, Haluzík M, Maletínská L, Kuneš J, Kuzma M. Tomášová P, et al. Among authors: kunes j. Appl Biochem Biotechnol. 2019 May;188(1):165-184. doi: 10.1007/s12010-018-2899-8. Epub 2018 Nov 5. Appl Biochem Biotechnol. 2019. PMID: 30393821

2

Angiotensin AT1 receptor blockade by specific antibody prevented two-kidney, one-clip renal hypertension in the rat.

Zelezná B, Veselský L, Velek J, Zicha J, Kunes J. Zelezná B, et al. Among authors: kunes j. Eur J Pharmacol. 1994 Jul 21;260(1):95-8. doi: 10.1016/0014-2999(94)90015-9. Eur J Pharmacol. 1994. PMID: 7525316

3

Blockade of AT1 receptors by specific antibody attenuated hypertension development in young spontaneously hypertensive rats.

Zelezná B, Velek J, Veselský L, Zicha J, Dobesová Z, Kunes J. Zelezná B, et al. Among authors: kunes j. Physiol Res. 1996;45(6):475-7. Physiol Res. 1996. PMID: 9085380 Free article.

4

Direct evidence for an angiotensin AT1 receptor type in rat vas deferens.

Maletínská L, Slaninová J, Kunes J, Zelezná B. Maletínská L, et al. Among authors: kunes j. Eur J Pharmacol. 1998 Jun 26;351(3):371-5. doi: 10.1016/s0014-2999(98)00380-x. Eur J Pharmacol. 1998. PMID: 9721030

5

Influence of active immunization against angiotensin AT1 or AT2 receptor on hypertension development in young and adult SHR.

Zelezná B, Veselský L, Velek J, Dobesová Z, Zicha J, Kunes J. Zelezná B, et al. Among authors: kunes j. Physiol Res. 1999;48(4):259-65. Physiol Res. 1999. PMID: 10638677 Free article.

6

LVV-hemorphin-7 lowers blood pressure in spontaneously hypertensive rats: radiotelemetry study.

Cejka J, Zelezná B, Velek J, Zicha J, Kunes J. Cejka J, et al. Among authors: kunes j. Physiol Res. 2004;53(6):603-7. Physiol Res. 2004. PMID: 15588127 Free article.

7

Obesity-related hypertension: possible pathophysiological mechanisms.

Vaněčková I, Maletínská L, Behuliak M, Nagelová V, Zicha J, Kuneš J. Vaněčková I, et al. Among authors: kunes j. J Endocrinol. 2014 Dec;223(3):R63-78. doi: 10.1530/JOE-14-0368. J Endocrinol. 2014. PMID: 25385879 Review.

8

Novel lipidized analogs of prolactin-releasing peptide have prolonged half-lives and exert anti-obesity effects after peripheral administration.

Maletínská L, Nagelová V, Tichá A, Zemenová J, Pirník Z, Holubová M, Špolcová A, Mikulášková B, Blechová M, Sýkora D, Lacinová Z, Haluzík M, Železná B, Kuneš J. Maletínská L, et al. Among authors: kunes j. Int J Obes (Lond). 2015 Jun;39(6):986-93. doi: 10.1038/ijo.2015.28. Epub 2015 Mar 16. Int J Obes (Lond). 2015. PMID: 25771926

9

Effect of palmitoylated prolactin-releasing peptide on food intake and neural activation after different routes of peripheral administration in rats.

Mikulášková B, Zemenová J, Pirník Z, Pražienková V, Bednárová L, Železná B, Maletínská L, Kuneš J. Mikulášková B, et al. Among authors: kunes j. Peptides. 2016 Jan;75:109-17. doi: 10.1016/j.peptides.2015.11.005. Epub 2015 Nov 28. Peptides. 2016. PMID: 26643957

10

Epigenetics and a new look on metabolic syndrome.

Kuneš J, Vaněčková I, Mikulášková B, Behuliak M, Maletínská L, Zicha J. Kuneš J, et al. Physiol Res. 2015;64(5):611-20. doi: 10.33549/physiolres.933174. Physiol Res. 2015. PMID: 26680230 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

438 results

Search Page

Filters